609-38-1 | 2-Furamide

Packsize	Purity	Availability	Price	Discounted Price
250mg	96%	in stock	$15.00	$10.00
1g	96%	in stock	$22.00	$15.00
5g	96%	in stock	$53.00	$37.00
10g	96%	in stock	$86.00	$61.00
25g	96%	in stock	$198.00	$139.00
100g	96%	in stock	$603.00	$422.00

Description

• Catalog Number: AB62247
• Chemical Name: 2-Furamide
• CAS Number: 609-38-1
• Molecular Formula: C5H5NO2
• Molecular Weight: 111.0987
• MDL Number: MFCD00236147
• SMILES: NC(=O)c1ccco1
• NSC Number: 9351

Computed Properties

• Complexity: 103
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 8
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 1
• XLogP3: -0.1

Literature

• Asymmetric synthesis and cytotoxicity of (-)-saframycin A analogues.

  European journal of medicinal chemistry 20120301

• Cyclization vs. cyclization/dimerization in o-amidostilbene radical cation cascade reactions: the amide question.

  Molecules (Basel, Switzerland) 20110825

• An IMDAF cycloaddition approach toward the synthesis of the lycopodium alkaloid (±)-fawcettidine.

  The Journal of organic chemistry 20110415

• Simultaneous determination of diloxanide furoate and metronidazole in presence of diloxanide furoate degradation products.

  Journal of AOAC International 20110101

• Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds.

  Bioorganic & medicinal chemistry 20100915

• Cecal ameboma.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20100101

• Validation and application of chemometrics-assisted spectrophotometry and liquid chromatography for simultaneous determination of two ternary mixtures containing drotaverine hydrochloride.

  Journal of AOAC International 20100101

• Difficulties in the treatment of intestinal amoebiasis in mentally disabled individuals at a rehabilitation institution for the intellectually impaired in Japan.

  Chemotherapy 20100101

• Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate.

  International journal of pharmaceutics 20080709

• Stability indicating reversed-phase liquid chromatographic determination of metronidazole benzoate and diloxanide furoate as bulk drug and in suspension dosage form.

  Journal of pharmaceutical and biomedical analysis 20050915

• Stability studies on diloxanide furoate: effect of pH, temperature, gastric and intestinal fluids.

  Farmaco (Societa chimica italiana : 1989) 20040401

• Enzymatic hydrolysis of diloxanide furoate in the presence of beta-cyclodextrin and its methylated derivatives.

  International journal of pharmaceutics 20031128

• Intramolecular cyclization reactions of 5-halo- and 5-nitro-substituted furans.

  Organic letters 20030904

• Treatment of asymptomatic intestinal Entamoeba histolytica infection.

  The New England journal of medicine 20021024

• Synthesis and microbiological activity of some N-(2-hydroxy-4-substitutedphenyl)benzamides, phenylacetamides and furamides as the possible metabolites of antimicrobial active benzoxazoles.

  Farmaco (Societa chimica italiana : 1989) 20020601

• Stability indicating methods for the determination of diloxanide furoate.

  Journal of pharmaceutical and biomedical analysis 20020415

• Spectrophotometric determination of diloxanide furoate in its dosage forms.

  Farmaco (Societa chimica italiana : 1989) 20010901

• Molecular modelling of ligand-DNA minor groove binding: role of ligand-water interactions.

  Journal of biomolecular structure & dynamics 20010801

• Inhibition of Cryptosporidium infection in mice treated with a cyclodextrin inclusion complex with diloxanide furoate.

  Parasitology research 20010601

• Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 19920901